IGC Pharma, Inc. (IGC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q2 '25: 412K Q3 '25: 257K Q4 '25: 330K Q1 '26: 328K Q2 '26: 191K Q3 '26: 350K Q4 '26: 317K Q1 '27: 265K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Gross Profit Quarterly

0 70K 140K 210K Q2 '25: 198K Q3 '25: 104K Q4 '25: 154K Q1 '26: 154K Q2 '26: 99K Q3 '26: 44K Q4 '26: 55K Q1 '27: 48K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Income Quarterly

-3M -2M -1M 0 1M 2M 3M Q2 '25: -1.8M Q3 '25: -1.9M Q4 '25: -1.4M Q1 '26: -1.9M Q2 '26: -2.9M Q3 '26: -2.9M Q4 '26: -2.5M Q1 '27: -2.8M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Net Income Quarterly

-3M -2M -1M 0 1M 2M 3M Q2 '25: -1.7M Q3 '25: -1.8M Q4 '25: -1.2M Q1 '26: -1.6M Q2 '26: -1.8M Q3 '26: -726K Q4 '26: -2.4M Q1 '27: -2.9M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Cost of Revenue Quarterly

0 150K 300K 450K Q2 '25: 214K Q3 '25: 153K Q4 '25: 176K Q1 '26: 174K Q2 '26: 92K Q3 '26: 306K Q4 '26: 262K Q1 '27: 217K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q2 '25: -996K Q3 '25: -1.3M Q4 '25: -730K Q1 '26: -1.4M Q2 '26: -2.1M Q3 '26: -1.2M Q4 '26: -1.2M Q1 '27: -1.4M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q2 '25: -1M Q3 '25: -1.3M Q4 '25: -748K Q1 '26: -1.4M Q2 '26: -2.1M Q3 '26: -1.2M Q4 '26: -1.2M Q1 '27: -1.4M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '25: 72.8M Q2 '25: 76M Q3 '25: 77.6M Q4 '25: 79.7M Q1 '26: 83M Q2 '26: 90.5M Q4 '26: 98.2M Q1 '27: 100.3M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q4 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.21 -0.14 -0.07 0.00 0.07 0.14 0.21 Q2 '25: -0.18 Q3 '25: -0.11 Q4 '25: -0.09 Q1 '26: -0.08 Q2 '26: -0.08 Q3 '26: -0.07 Q4 '26: -0.07 Q1 '27: -0.08 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.